Polysaccharide Degradation by the Intestinal Microbiota and Its Influence on Human Health and Disease

Darrell Cockburn, Nicole M. Koropatkin

Research output: Contribution to journalReview article

82 Citations (Scopus)

Abstract

Carbohydrates comprise a large fraction of the typical diet, yet humans are only able to directly process some types of starch and simple sugars. The remainder transits the large intestine where it becomes food for the commensal bacterial community. This is an environment of not only intense competition but also impressive cooperation for available glycans, as these bacteria work to maximize their energy harvest from these carbohydrates during their limited transit time through the gut. The species within the gut microbiota use a variety of strategies to process and scavenge both dietary and host-produced glycans such as mucins. Some act as generalists that are able to degrade a wide range of polysaccharides, while others are specialists that are only able to target a few select glycans. All are members of a metabolic network where substantial cross-feeding takes place, as by-products of one organism serve as important resources for another. Much of this metabolic activity influences host physiology, as secondary metabolites and fermentation end products are absorbed either by the epithelial layer or by transit via the portal vein to the liver where they can have additional effects. These microbially derived compounds influence cell proliferation and apoptosis, modulate the immune response, and can alter host metabolism. This review summarizes the molecular underpinnings of these polysaccharide degradation processes, their impact on human health, and how we can manipulate them through the use of prebiotics.

Original languageEnglish (US)
Pages (from-to)3230-3252
Number of pages23
JournalJournal of Molecular Biology
Volume428
Issue number16
DOIs
StatePublished - Aug 14 2016

Fingerprint

Polysaccharides
Health
Carbohydrates
Prebiotics
Large Intestine
Mucins
Portal Vein
Metabolic Networks and Pathways
Starch
Fermentation
Cell Proliferation
Gastrointestinal Microbiome
Apoptosis
Diet
Bacteria
Food
Liver

All Science Journal Classification (ASJC) codes

  • Structural Biology
  • Molecular Biology

Cite this

@article{3ab5f5edfbde4bd9889e16fd8ca2a4ae,
title = "Polysaccharide Degradation by the Intestinal Microbiota and Its Influence on Human Health and Disease",
abstract = "Carbohydrates comprise a large fraction of the typical diet, yet humans are only able to directly process some types of starch and simple sugars. The remainder transits the large intestine where it becomes food for the commensal bacterial community. This is an environment of not only intense competition but also impressive cooperation for available glycans, as these bacteria work to maximize their energy harvest from these carbohydrates during their limited transit time through the gut. The species within the gut microbiota use a variety of strategies to process and scavenge both dietary and host-produced glycans such as mucins. Some act as generalists that are able to degrade a wide range of polysaccharides, while others are specialists that are only able to target a few select glycans. All are members of a metabolic network where substantial cross-feeding takes place, as by-products of one organism serve as important resources for another. Much of this metabolic activity influences host physiology, as secondary metabolites and fermentation end products are absorbed either by the epithelial layer or by transit via the portal vein to the liver where they can have additional effects. These microbially derived compounds influence cell proliferation and apoptosis, modulate the immune response, and can alter host metabolism. This review summarizes the molecular underpinnings of these polysaccharide degradation processes, their impact on human health, and how we can manipulate them through the use of prebiotics.",
author = "Darrell Cockburn and Koropatkin, {Nicole M.}",
year = "2016",
month = "8",
day = "14",
doi = "10.1016/j.jmb.2016.06.021",
language = "English (US)",
volume = "428",
pages = "3230--3252",
journal = "Journal of Molecular Biology",
issn = "0022-2836",
publisher = "Academic Press Inc.",
number = "16",

}

Polysaccharide Degradation by the Intestinal Microbiota and Its Influence on Human Health and Disease. / Cockburn, Darrell; Koropatkin, Nicole M.

In: Journal of Molecular Biology, Vol. 428, No. 16, 14.08.2016, p. 3230-3252.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Polysaccharide Degradation by the Intestinal Microbiota and Its Influence on Human Health and Disease

AU - Cockburn, Darrell

AU - Koropatkin, Nicole M.

PY - 2016/8/14

Y1 - 2016/8/14

N2 - Carbohydrates comprise a large fraction of the typical diet, yet humans are only able to directly process some types of starch and simple sugars. The remainder transits the large intestine where it becomes food for the commensal bacterial community. This is an environment of not only intense competition but also impressive cooperation for available glycans, as these bacteria work to maximize their energy harvest from these carbohydrates during their limited transit time through the gut. The species within the gut microbiota use a variety of strategies to process and scavenge both dietary and host-produced glycans such as mucins. Some act as generalists that are able to degrade a wide range of polysaccharides, while others are specialists that are only able to target a few select glycans. All are members of a metabolic network where substantial cross-feeding takes place, as by-products of one organism serve as important resources for another. Much of this metabolic activity influences host physiology, as secondary metabolites and fermentation end products are absorbed either by the epithelial layer or by transit via the portal vein to the liver where they can have additional effects. These microbially derived compounds influence cell proliferation and apoptosis, modulate the immune response, and can alter host metabolism. This review summarizes the molecular underpinnings of these polysaccharide degradation processes, their impact on human health, and how we can manipulate them through the use of prebiotics.

AB - Carbohydrates comprise a large fraction of the typical diet, yet humans are only able to directly process some types of starch and simple sugars. The remainder transits the large intestine where it becomes food for the commensal bacterial community. This is an environment of not only intense competition but also impressive cooperation for available glycans, as these bacteria work to maximize their energy harvest from these carbohydrates during their limited transit time through the gut. The species within the gut microbiota use a variety of strategies to process and scavenge both dietary and host-produced glycans such as mucins. Some act as generalists that are able to degrade a wide range of polysaccharides, while others are specialists that are only able to target a few select glycans. All are members of a metabolic network where substantial cross-feeding takes place, as by-products of one organism serve as important resources for another. Much of this metabolic activity influences host physiology, as secondary metabolites and fermentation end products are absorbed either by the epithelial layer or by transit via the portal vein to the liver where they can have additional effects. These microbially derived compounds influence cell proliferation and apoptosis, modulate the immune response, and can alter host metabolism. This review summarizes the molecular underpinnings of these polysaccharide degradation processes, their impact on human health, and how we can manipulate them through the use of prebiotics.

UR - http://www.scopus.com/inward/record.url?scp=84979556395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979556395&partnerID=8YFLogxK

U2 - 10.1016/j.jmb.2016.06.021

DO - 10.1016/j.jmb.2016.06.021

M3 - Review article

VL - 428

SP - 3230

EP - 3252

JO - Journal of Molecular Biology

JF - Journal of Molecular Biology

SN - 0022-2836

IS - 16

ER -